Changbin Zhu

Application of NGS molecular classification in the diagnosis of endometrial carcinoma: A supplement to traditional pathological diagnosis

Hui Zhou, Qunxian Rao, Xin Zhang, 2022, Cancer medicine.

PLEK2 and IFI6, representing mesenchymal and immune-suppressive microenvironment, predicts resistance to neoadjuvant immunotherapy in esophageal squamous cell carcinoma

Shuaitong Zhang, G. Qiao, Ji-ming Tang, 2022, Cancer Immunology, Immunotherapy.

Short-term dynamics of circulating tumor DNA predicting efficacy of sintilimab plus docetaxel in second-line treatment of advanced NSCLC: biomarker analysis from a single-arm, phase 2 trial

Xiangjiao Meng, Yulan Sun, Zhong-tang Wang, 2022, Journal for ImmunoTherapy of Cancer.

COL19A1 is a predictive biomarker for the responsiveness of esophageal squamous cell carcinoma patients to immune checkpoint therapy

G. Qiao, Q. Qiu, Weiwei Li, 2023, Thoracic cancer.

Validation of a one-step genomics-based molecular classifier for endometrial carcinoma in a large Chinese population.

Zhiqi Wang, F. Gai, Y. Dai, 2024, Pathology, research and practice.